Article Versions Notes

Alvim RG, Georgala P, Nogueira L, Somma AJ, Nagar K, Thomas J, Alvim L, Riegel A, Hughes C, Chen J, et al. Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model. Molecules. 2021; 26(12):3744. https://doi.org/10.3390/molecules26123744

Alvim, Ricardo G., Petrina Georgala, Lucas Nogueira, Alexander J. Somma, Karan Nagar, Jasmine Thomas, Laura Alvim, Amelia Riegel, Christopher Hughes, Jie Chen, and et al. 2021. "Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model" Molecules 26, no. 12: 3744. https://doi.org/10.3390/molecules26123744

Alvim, R. G., Georgala, P., Nogueira, L., Somma, A. J., Nagar, K., Thomas, J., Alvim, L., Riegel, A., Hughes, C., Chen, J., Reis, A. B., Lebdai, S., Scherz, A., Zanganeh, S., Gardner, R., Kim, K., & Coleman, J. A. (2021). Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model. Molecules, 26(12), 3744. https://doi.org/10.3390/molecules26123744